SCHEMBL30180643

SCHEMBL30180643

COC(=O)NC(=N)c1ccc2cc(C(=O)Nc3ccc(N4CCCC4)cc3)n(Cc3ccc(C(N)=O)cc3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 11/20 0.44
▸ RAB9A P51151 7/20 0.44
▸ MEN1 O00255 7/20 0.44
▸ NPC1 O15118 5/20 0.44
▸ USP2 O75604 4/20 0.44
▸ MAPT P10636 14/20 0.42
▸ ALDH1A1 P00352 8/20 0.42
▸ MCL1 Q07820 3/20 0.42
▸ NR4A1 P22736 1/20 0.42
▸ SMN1; SMN2 Q16637 8/20 0.41
▸ POLB P06746 1/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ LMNA P02545 3/20 0.40
▸ QSOX1 O00391 1/20 0.40
▸ PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25016067 1.00 KMT2A (0.44) KMT2ARAB9AMEN1NPC1USP2
SCHEMBL25016197 0.94 F10 (0.42) KMT2ARAB9AMEN1NPC1USP2
SCHEMBL21822273 0.92 NPC1 (0.43) KMT2ARAB9AMEN1NPC1USP2
SCHEMBL25015851 0.89 PLG (0.47) KMT2ARAB9AMEN1NPC1USP2
SCHEMBL25015847 0.88 PLG (0.47) KMT2ARAB9AMEN1NPC1USP2
SCHEMBL25017321 0.86 MAPT (0.40) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL25017852 0.86 F10 (0.42) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL25015717 0.84 MAPT (0.39) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL25015711 0.84 MAPT (0.39) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL25016691 0.84 RAB9A (0.45) KMT2ARAB9AMEN1NPC1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3860636-B1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE INC (US) 2026-01-28 — — EP disclosed
US-12428415-B2 Matriptase 2 inhibitors and uses thereof DISC MEDICINE, INC. (US) 2025-09-30 — — US disclosed
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF DISC MEDICINE, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12428415-B2 Matriptase 2 inhibitors and uses thereof MMP7, MATR3, SPINT2 KMT2A 1072/4885RAB9A 4274/4885MEN1 772/4885
US-20230043159-A1 MATRIPTASE 2 INHIBITORS AND USES THEREOF MMP7, MATR3, SPINT2 KMT2A 1072/4885RAB9A 4274/4885MEN1 772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback